Q2 FY2026 · ended Jun 30, 2026 · Revenue $3.64M, +9.9% YoY · Filed Aug 13, 2026
CapsoVision, Inc (CV) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.6 million and a net loss of $7.5 million. Free cash flow was -$8.4 million.
Revenue
$3.64M
+9.9% vs year-ago quarter
Net income
$-7.48M
-61.8% vs year-ago quarter
Operating cash flow
$-8.40M
+11.7% vs year-ago quarter
Free cash flow
$-8.40M
+12.3% vs year-ago quarter
EPS
$-0.15
+92.6% vs year-ago quarter
Dividend per share
None
Shares outstanding
50.05M
+7.0% vs year-ago quarter
Net cash
—
Operating margin
-217.1%
TTM
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Saratoga, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1378325
- Former names
- Capso Vision Inc (until Feb 21, 2014)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.6M | $2.8M | $3.9M | $3.5M | $3.3M |
| Operating income | -$7.6M | -$7.1M | -$7.5M | -$8.0M | -$4.7M |
| Net income | -$7.5M | -$7.0M | -$7.4M | -$7.9M | -$4.6M |
| Diluted EPS | -$0.15 | -$0.15 | -$0.16 | -$0.17 | -$2.02 |
| Operating cash flow | -$8.4M | -$6.1M | -$7.7M | -$5.7M | -$9.5M |
| Free cash flow | -$8.4M | -$6.1M | -$7.7M | -$5.7M | -$9.6M |
| Total assets | $18.6M | $25.9M | $18.2M | $25.7M | $9.5M |
| Total liabilities | $5.4M | $5.7M | $4.9M | $5.2M | $4.9M |
| Stockholders' equity | $13.2M | $20.2M | $13.3M | $20.4M | -$139.0M |
| Total debt | $687,000 | $788,000 | $887,000 | $978,000 | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 18, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Other events
|
Aug 18, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 2, 2026 | Jul 1, 2026 |
All 141 CapsoVision, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.